Osseous sarcoidosis: a case series

Rheumatology International

Volumn 35, Issue 5, 2015, Pages 925-933

  Kuzyshyn, Halyna ^a   Feinstein, David ^a   Kolasinski, Sharon L ^a   Eid, Hala ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

Author keywords

Bone lesions; Cytokines; Granuloma; Radiographic imaging; Sarcoidosis

Indexed keywords

ADULT; BONE DISEASES; CASE REPORT; FEMALE; FEMUR; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SARCOIDOSIS; SPINE; TIBIA;

ADULT; BONE DISEASES; FEMALE; FEMUR; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SARCOIDOSIS; SPINE; TIBIA;

EID: 84939989929     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-014-3170-4     Document Type: Article

References (55)

1. James DG, Neville E, Siltzbach LE (1976) A worldwide review of sarcoidosis. Ann NY Acad Sci 278:321–334
2. Shorr AF, Murphy FT, Gilliland WR, Hnatiuk W (2000) Osseous disease in patients with pulmonary sarcoidosis and musculoskeletal symptoms. Respir Med 94(3):228–232
3. Chatham W (2010) Rheumatic manifestations of systemic disease: sarcoidosis. Curr Opin Rheumatol 22(1):85–90
4. Ugwonali OF, Parisien M, Nickerson KG, Scully B, Ristic S, Strauch RJ (2005) Osseous sarcoidosis of the hand: pathologic analysis and review of the literature. J Hand Surg Am 30(4):854–858
5. Talmi D, Smith S, Mulligan ME (2008) Central skeletal sarcoidosis mimicking metastatic disease. Skeletal Radiol 37(8):757–761
6. Waanders F, van Hengel P, Krikke A, Wesseling J, Nieboer P (2006) Sarcoidosis mimicking metastatic disease: a case report and review of the literature. Neth J Med 64(9):342–345
7. Fisher AJ, Gilula LA, Kyriakos M, Holzaepfel CD (1999) MR imaging changes of lumbar vertebral sarcoidosis. AJR Am J Roentgenol 173(2):354–356
8. Lisle D, Mitchell K, Crouch M, Windsor M (2004) Sarcoidosis of the thoracic and lumbar spine: imaging findings with an emphasis on magnetic resonance imaging. Australas Radiol 48(3):404–407
9. Poyanli A, Poyanli O, Sencer S, Akan K, Sayrak H, Acunaş B (2000) Vertebral sarcoidosis: imaging findings. Eur Radiol 10(1):92–94
10. Rúa-Figueroa I, Gantes MA, Erausquin C, Mhaidli H, Montesdeoca A (2002) Vertebral sarcoidosis: clinical and imaging findings. Semin Arthritis Rheum 31(5):346–352
11. Binicier O, Sari I, Sen G, Onen F, Akkoc N, Manisali M, Akar S (2009) Axial sarcoidosis mimicking radiographic sacroiliitis. Rheumatol Int 29(3):343–345
12. Yaghmai I (1983) Radiographic, angiographic and radionuclide manifestations of osseous sarcoidosis. RadioGraphics 3(3):375–396
13. Mostard RL, Prompers L, Weijers RE, van Kroonenburgh MJ, Wijnen PA, Geusens PP, Drent M (2012) F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients. Clin Nucl Med 37(1):21–25
14. Mostard RL, Vöö S, van Kroonenburgh MJ, Verschakelen JA, Wijnen PA, Nelemans PJ, Erckens RJ, Drent M (2011) Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis. Respir Med 105(12):1917–1924
15. Sun SS, Tsai SC, Hung CJ, Tsai PP, Kao CH (2001) Tc-99m MDP and Ga-67 citrate scintigraphic findings in sarcoidosis with osseous involvement. Clin Nucl Med 26(5):472–473
16. Moore SL, Kransdorf MJ, Schweitzer ME, Murphey MD, Babb JS (2012) Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI? AJR Am J Roentgenol 198(6):1387–1393
17. Moore SL, Teirstein AE (2003) Musculoskeletal sarcoidosis: spectrum of appearances at MR imaging. Radiographics 23(6):1389–1399
18. Moore SL, Teirstein A, Golimbu C (2005) MRI of sarcoidosis patients with musculoskeletal symptoms. AJR Am J Roentgenol 185(1):154–159
19. Johns CJ, Michele TM (1999) The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 78(2):65–111
20. Johnson AK, Johnson JM, Ames E, Filippi C (2012) Spontaneous clinical and radiological resolution of vertebral sarcoidosis: a case report. Spine (Phila Pa 1976) 37(6):E414–E416
21. Salmon JH, Perotin JM, Direz G, Brochot P, Laredo JD, Eschard JP (2013) Vertebral sarcoidosis. Spontaneous favorable outcome: a case report and literature review. Rev Med Interne 34(1):42–46
22. Shorr AF, Murphy FT, Kelly WF, Kaplan KJ, Gilliland WR, Shapeero LG (1998) Osseous sarcoidosis clinical, radiographic, and therapeutic observations. J Clin Rheumatol 4(4):186–192
23. Wilcox A, Bharadwaj P, Sharma OP (2000) Bone sarcoidosis. Curr Opin Rheumatol 12(4):321–330
24. Mitchell DN (1998) Sarcoidosis with skeletal involvement. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby International, London, pp 26.1–26.8
25. Maña J, Gómez-Vaquero C, Dorca J, Pujol R (1999) Vertebral and rib sarcoidosis: long-term clinical remission with methotrexate. Clin Rheumatol 18(6):492–494
26. Sakellariou GT, Anastasilakis AD, Karanikolas D, Vounotrypidis P, Berberidis C (2013) Central skeletal sarcoidosis: a case report with sustained remission only on methotrexate, and a literature review on the imaging approach, treatment, and assessment of disease activity. Mod Rheumatol 23(1):175–181
27. Kaye O, Palazzo E, Grossin M, Bourgeois P, Kahn MF, Malaise MG (1995) Low-dose methotrexate: an effective corticosteroid-sparing agent in the musculoskeletal manifestations of sarcoidosis. Br J Rheumatol 34(7):642–644
28. Lower EE, Baughman RP (1990) The use of low dose methotrexate in refractory sarcoidosis. Am J Med Sci 299(3):153–157
29. Vucinic VM (2002) What is the future of methotrexate in sarcoidosis? A study and review. Curr Opin Pulm Med 8(5):470–476
30. Agostini C, Adami F, Semenzato G (2000) New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12(1):71–76
31. Semenzato G, Pezzutto A, Chilosi M, Pizzolo G (1982) Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med 306(1):48–49
32. Kasahara K, Kobayashi K, Shikama Y, Yoneya I, Kaga S, Hashimoto M, Odagiri T, Soejima K, Ide H, Takahashi T et al (1989) The role of monokines in granuloma formation in mice: the ability of interleukin 1 and tumor necrosis factor-alpha to induce lung granulomas. Clin Immunol Immunopathol 51(3):419–425
33. Bargagli E, Mazzi A, Rottoli P (2008) Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med 29(3):445–458
34. Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S, Sato N (2001) IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166(1):642–649
35. Elliott M, Benson J, Blank M, Brodmerkel C, Baker D, Sharples KR, Szapary P (2009) Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases. Ann NY Acad Sci 1182:97–110
36. Larousserie F, Pflanz S, Coulomb-L’Herminé A, Brousse N, Kastelein R, Devergne O (2004) Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 202(2):164–171
37. Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, Semenzato G, Agostini C (2011) Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 66(2):144–150
38. Ramos-Casals M, Brito-Zerón P, Muñoz S, Soto MJ, BIOGEAS STUDY Group (2008) A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore) 87(6):345–364
39. Bargagli E, Olivieri C, Rottoli P (2011) Cytokine modulators in the treatment of sarcoidosis. Rheumatol Int 31(12):1539–1544
40. Chen ES, Moller DR (2011) Sarcoidosis–scientific progress and clinical challenges. Nat Rev Rheumatol 7(8):457–467
41. Baughman RP, Strohofer SA, Buchsbaum J, Lower EE (1990) Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med 115(1):36–42
42. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vuk-Pavlovic Z, Schroeder DR (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124(1):177–185
43. Khanna D, Liebling MR, Louie JS (2003) Etanercept ameliorates sarcoidosis arthritis and skin disease. J Rheumatol 30(8):1864–1867
44. Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127(3):1064–1071
45. Roberts SD, Wilkes DS, Burgett RA, Knox KS (2003) Refractory sarcoidosis responding to infliximab. Chest 124(5):2028–2031
46. Rossman MD, Newman LS, Baughman RP, Teirstein A, Weinberger SE, Miller W Jr, Sands BE (2006) A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 23(3):201–208
47. Callejas-Rubio JL, Ortego-Centeno N, Lopez-Perez L, Benticuaga MN (2006) Treatment of therapy-resistant sarcoidosis with adalimumab. Clin Rheumatol 25(4):596–597
48. Baughman RP, Lower EE, Drent M (2008) Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis 25(2):76–89
49. Vigne C, Tebib JG, Pacheco Y, Coury F (2013) Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy. Joint Bone Spine 80(1):104–107
50. Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, Samimi M, Pavy S, Pertuiset E, Toussirot E, Combe B, Morel J (2009) Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Club Rhumatismes et Inflammation (CRI). Rheumatology (Oxford) 48(8):883–886
51. Bosè F, Raeli L, Garutti C, Frigerio E, Cozzi A, Crimi M, Caprioli F, Scavelli R, Altomare G, Geginat J, Abrignani S, Reali E (2011) Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Clin Immunol 139(2):164–176
52. Tong D, Manolios N, Howe G, Spencer D (2012) New onset sarcoid-like granulomatosis developing during anti-TNF therapy: an under-recognised complication. Intern Med J 42(1):89–94
53. Banse C, Bisson-Vaivre A, Kozyreff-Meurice M, Vittecoq O, Goëb V (2013) No impact of tumor necrosis-factor antagonists on the joint manifestations of sarcoidosis. Int J Gen Med 22(6):605–611
54. Garg S, Garg K, Altaf M, Magaldi JA (2008) Refractory vertebral sarcoidosis responding to infliximab. J Clin Rheumatol 14(4):238–240
55. Hasni SA, Kunz D, Finzel K, Gruber BL (2010) Osseous sarcoidosis treated with tumor necrosis factor-inhibitors: case report and review of the literature. Spine 35(18):E904–E907